Buy or sell Sana Biotechnology stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
2021 IPO
Sana Biotechnology Stock
Sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients.
About Sana Biotechnology Stock
Sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients. Recent scientific advances make it possible to reprogram cells in the body or replace damaged cells and tissues, creating a new class of medicines to treat a broad array of diseases. The company is a team of scientists, clinicians and biotechnology veterans focused on creating an enduring company that makes meaningful medicines and will change the approach in treating diseases.
Management
Chief Business Officer
Christian Hordo
Chief Financial Officer
Nate Hardy
Chief Scientific Officer
Chad Cowan
President and Chief Executive Officer
Steve Harr
Chief Technology Officer
Andy May
General Counsel
James MacDonald
Chief Development Officer and Head of Portfolio Strategy
Sunil Agarwal
Chief People Officer
Robin Andrulevich
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
